Adipokines exhibit context-dependent interactions with diverse cancers, so it is not surprising, for instance, that even though adiponectin is proven to have a guardian angel effect in an otherwise malignant tumor, including breast cancer, the same does not hold true in clinical studies or mechanistic studies concerning PC (79, 80). This evidence concerns the gene ADIPOQ and breast cancer.